News Archives

Rodos Biotarget Receives Government Funding for Developing Antibiotic-loaded Nanocarriers

Three-year funding of EUR 2.8 million for top-tier research consortium by Germany’s BMBF. Towards advancing targeted drug application to manage treatment-resistant pathogens  Hannover, Germany, 16 October 2017. In recent years, antibiotic resistances of bacterial pathogens have reached a threatening dimension

Posted in Press

Louis Capozzi Receives PRSAs Gold Anvil Award for Lifetime Achievement in Public Relations

NEW YORK (Oct. 8, 2017) — The Public Relations Society of America (PRSA) presented Louis Capozzi, APR, Fellow PRSA, with its Gold Anvil Award, the Society’s highest individual award and considered to be the Society’s lifetime achievement award. The award was presented at

Posted in Press

Cancer Research Online Crowdsourcing Campaign Passes 78% of Funding Goal

An early-stage drug development company in South Carolina has launched an online fundraising campaign to study the ancient spice curcumin in combination with an FDA-approved Immune Checkpoint Inhibitor to fight colon cancer. Download and read the Press Release [PDF]

Posted in Press

Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget

Hannover, 17 August 2017. Rodos Biotarget is the first German life-science company to initiate crowdfunding campaigns via two crowd platforms. In 2016, a first round took place with Seedmatch, and a current financing round is running with Hannover, 17 August

Posted in Press

Deutsche Börse welcomes Rodos Biotarget to the Venture Network

Hannover, 24 August 2016. Rodos Biotarget GmbH is pleased about its membership in the Deutsche Börse Venture Network (DBVN). Access to the non-public network is based on a qualification process; several criteria must be met in order to join the network. The Venture Network is a platform designed to bring classified high-growth companies and international investors from the categories PE/VC, Family Office, High Net Worth Individuals (HNWI) and Public Equity together and create an environment for effective growth financing.

Posted in Press